cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Accession match over (% length) |
Base differences relative to genome (% identity) |
AK026231 | human small intestine | .b | 20 to 1302 | 1 to 1283 | exact | tiling clone, available from FLJ, AAA | 1283/1283 (100 %) | 4 diff (99.7 %id) |
AK225449 | small intestine | .b | 20 to 1193 | 1 to 1174 | exact | tiling clone, | 1174/1174 (100 %) | 3 diff (99.8 %id) |
AK292307 | testis | .a | 713 to 1268 | 764 to 1319 | exact | 1319/1319 (100 %) | 1 diff (100.0 %id) | |
BC072411 | Skin, melanotic melanoma. | .a | 16 to 1787 | 1 to 1772 | exact | tiling clone, available from MGC, AAA | 1772/1772 (100 %) | 4 diff (99.8 %id) |
BF172844 | blood | .a | 1379 to 1564 | 1 to 189 | 189/189 (100 %) | 3 diff (98.5 %id) | ||
BI036403 | nervous_tumor | .a | 216 to 614 | 6 to 402 | 397/402 (98 %) | 6 diff (98.6 %id) | ||
DA252215 | caudate nucleus | .a | -9 to 563 | 2 to 576 | capped | 575/575 (100 %) | 1 diff (99.9 %id) | |
DA254259 | caudate nucleus | .a | 240 to 795 | 2 to 557 | capped | 556/556 (100 %) | 0 diff (100 %id) | |
DA271129 | caudate nucleus | .a | -9 to 564 | 2 to 575 | tiling clone, capped | 574/574 (100 %) | 2 diff (99.7 %id) | |
BX115064 | pooled germ cell tumors | .d-u | 1 to 570 | 1 to 570 | exact | tiling clone, | 570/570 (100 %) | 1 diff (99.9 %id) |
CR457357 | .a | 765 to 1228 | 1 to 464 | 464/468 (99 %) | 1 diff (99.8 %id) | |||
CR601982 | Placenta Cot 25-normalized | .a | 713 to 1756 | 748 to 1791 | exact | 1791/1791 (100 %) | 0 diff (100 %id) | |
CR607365 | B cells (Ramos cell line) Cot 25-normalized | .a | 713 to 1751 | 782 to 1820 | exact | 1820/1820 (100 %) | 0 diff (100 %id) | |
CR616141 | placenta | .a | 713 to 1768 | 739 to 1794 | exact | 1794/1794 (100 %) | 0 diff (100 %id) | |
CR618401 | B cells (Ramos cell line) Cot 25-normalized | .a | 16 to 1758 | 1 to 1743 | exact | tiling clone, | 1743/1743 (100 %) | 0 diff (100 %id) |
CR622648 | Neuroblastoma Cot 25-normalized | .a | 713 to 1778 | 782 to 1847 | exact | 1847/1847 (100 %) | 0 diff (100 %id) | |
AL523358 | brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized | .a | 886 to 1778 | 889 to 1 | fully sequenced, | 889/889 (100 %) | 15 diff (98.4 %id) | |
AL523359 | brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized | .a | 713 to 916 | 779 to 983 | fully sequenced, | 959/983 (97 %) | 10 diff (99.0 %id) | |
BX375757 | Neuroblastoma Cot 25-normalized | .a | 801 to 1732 | 947 to 22 | 926/947 (97 %) | 9 diff (99.1 %id) | ||
BX375758 | Neuroblastoma Cot 25-normalized | .a | 713 to 806 | 784 to 879 | 866/879 (98 %) | 8 diff (99.1 %id) | ||
BX438850 | placenta | .a | 852 to 1768 | 915 to 1 | fully sequenced, | 915/915 (100 %) | 6 diff (99.4 %id) | |
BX458442 | placenta | .a | 713 to 882 | 739 to 909 | fully sequenced, | 909/909 (100 %) | 1 diff (99.9 %id) | |
BX439665 | placenta | .a | 713 to 806 | 777 to 870 | 870/870 (100 %) | 41 diff (95.3 %id) | ||
BX358648 | Placenta Cot 25-normalized | .a | 809 to 1756 | 947 to 1 | fully sequenced, | 947/947 (100 %) | 4 diff (99.6 %id) | |
BX358649 | Placenta Cot 25-normalized | .a | 713 to 839 | 748 to 871 | fully sequenced, | 871/871 (100 %) | 1 diff (99.9 %id) | |
BX401803 | .a | 744 to 1746 | 1006 to 5 | fully sequenced, | 1002/1006 (99 %) | 4 diff (99.7 %id) | ||
BX401804 | .a | 713 to 774 | 779 to 841 | fully sequenced, | 818/841 (97 %) | 8 diff (99.1 %id) | ||
BX349372 | .a | 659 to 1483 | 1 to 839 | 839/886 (94 %) | 29 diff (96.8 %id) | |||
BX385548 | .a | 852 to 1758 | 906 to 1 | 906/906 (100 %) | 8 diff (99.2 %id) | |||
BX385549 | .a | 16 to 805 | 1 to 790 | 790/790 (100 %) | 0 diff (100 %id) | |||
BX392037 | .a | 187 to 1105 | 918 to 1 | 918/954 (96 %) | 19 diff (98.1 %id) | |||
CV028124 | mixed | .a | 801 to 1231 | 37 to 467 | 431/588 (73 %) | 7 diff (98.9 %id) | ||
BP225210 | .c | 27 to 599 | 1 to 573 | exact | tiling clone, | 573/582 (98 %) | 1 diff (99.9 %id) | |
BX504488 | .a | 249 to 864 | 1 to 617 | 617/617 (100 %) | 3 diff (99.6 %id) | |||
EL736747 | mixed | .a | 171 to 793 | 1 to 624 | 624/626 (99 %) | 5 diff (99.3 %id) | ||
BP261116 | small intestine | .b | 20 to 601 | 1 to 582 | 582/582 (100 %) | 3 diff (99.5 %id) | ||
AA528208 | normal prostate, Prostate | .a | 1660 to 1780 | 122 to 1 | 122/122 (100 %) | 3 diff (97.6 %id) | ||
AA633154 | colon, colon tumor RER+ | .a | 1628 to 1781 | 160 to 6 | 155/160 (96 %) | 0 diff (100 %id) | ||
AA931152 | pooled germ cell tumors | .d-u | 110 to 627 | 517 to 1 | 517/517 (100 %) | 2 diff (99.7 %id) | ||
AI422635 | Prostate | .a | 1658 to 1739 | 126 to 45 | 82/89 (92 %) | 0 diff (100 %id) | ||
AI611025 | Prostate | .a | 1657 to 1780 | 124 to 1 | 124/124 (100 %) | 0 diff (100 %id) | ||
AI675805 | Prostate | .a | 1659 to 1781 | 123 to 1 | 123/123 (100 %) | 0 diff (100 %id) | ||
AI918059 | Prostate | .a | 1659 to 1780 | 122 to 1 | 122/122 (100 %) | 2 diff (98.4 %id) | ||
AI990504 | pooled germ cell tumors | .d-u | 98 to 630 | 537 to 5 | tiling clone, | 533/537 (99 %) | 0 diff (100 %id) | |
AW204625 | .d-u | 256 to 627 | 389 to 18 | AAA | 372/372 (100 %) | 0 diff (100 %id) | ||
AW517016 | cervix | .a | 1413 to 1780 | 367 to 1 | 367/367 (100 %) | 3 diff (99.2 %id) | ||
AW651675 | cervical carcinoma cell line, cervix | .c | 14 to 392 | 1 to 379 | 379/379 (100 %) | 1 diff (99.8 %id) | ||
AW613641 | 2 pooled high-grade transitional celltumors, genitourinary tract | .b | 1036 to 1303 | 275 to 8 | tiling clone, | 268/280 (95 %) | 0 diff (100 %id) | |
AW663201 | 2 pooled high-grade transitional celltumors, genitourinary tract | .b | 1 to 204 | 1 to 204 | tiling clone, | 204/204 (100 %) | 0 diff (100 %id) | |
BF510687 | .a | 1626 to 1780 | 173 to 18 | AAA | 156/166 (93 %) | 1 diff (99.4 %id) | ||
BC009416 | Kidney, renal cell adenocarcinoma | .a | 455 to 1787 | 1 to 1333 | available from MGC, AAA | 1333/1333 (100 %) | 0 diff (100 %id) | |
BE273103 | Kidney, renal cell adenocarcinoma | .a | 474 to 1069 | 1 to 599 | available from MGC, | 599/600 (99 %) | 12 diff (98.0 %id) | |
BG393695 | embryonal carcinoma, cell line, testis | .a | -11 to 701 | 1 to 707 | 707/947 (74 %) | 15 diff (98.5 %id) | ||
BI258400 | cervical carcinoma cell line, cervix | .a | 5 to 729 | 1 to 724 | 724/724 (100 %) | 9 diff (98.8 %id) | ||
BM558424 | amelanotic melanoma, cell line, skin | .a | 683 to 1411 | 1 to 734 | 734/1089 (67 %) | 19 diff (98.3 %id) | ||
BU074173 | insulinoma, Pancreas | .a | 1526 to 1780 | 273 to 19 | fully sequenced, AAA | 255/255 (100 %) | 0 diff (100 %id) | |
BU579451 | insulinoma, Pancreas | .a | 1511 to 1556 | 1 to 46 | fully sequenced, | 46/46 (100 %) | 5 diff (89.2 %id) | |
BU161348 | melanotic melanoma, skin | .a | 17 to 806 | 1 to 798 | 798/842 (94 %) | 13 diff (98.5 %id) | ||
BQ672610 | epidermoid carcinoma, cell line, salivary gland | .a | 757 to 1532 | 1 to 797 | 797/984 (80 %) | 37 diff (96.3 %id) | ||
CF129667 | Chondrosarcoma Lung Metastasis cell lines, lung | .a | 1233 to 1609 | 1 to 377 | 377/377 (100 %) | 0 diff (100 %id) | ||
NM_024864.3 | .a | 713 to 1787 | 758 to 1832 | exact | RefSeq, AAA | 1832/1832 (100 %) | 0 diff (100 %id) | |
DA700535 | .a | 43 to 562 | 2 to 522 | capped | 521/521 (100 %) | 2 diff (99.7 %id) | ||
DB323675 | .a | 1250 to 1785 | 536 to 1 | 536/536 (100 %) | 1 diff (99.9 %id) | |||
DA823727 | pericardium | .c | 1 to 570 | 4 to 588 | capped | 587/587 (100 %) | 15 diff (97.5 %id) | |
BM838212 | Ascites, stomach | .c | -8 to 542 | 1 to 551 | tiling clone, | 551/551 (100 %) | 3 diff (99.5 %id) | |
TI_1948232139 | .a | 170 to 1060 | 130 to 1024 | 895/1246 (71 %) | 27 diff (97.9 %id) | |||
TI_1948232140 | .a | 170 to 870 | 130 to 835 | 706/1092 (64 %) | 13 diff (98.9 %id) | |||
TI_1948232141 | .a | 521 to 1231 | 821 to 112 | 710/1245 (57 %) | 16 diff (98.8 %id) | |||
TI_1948232142 | .a | 361 to 1231 | 1007 to 127 | 881/1295 (68 %) | 20 diff (98.5 %id) | |||
TI_1948232437 | .a | 170 to 1060 | 134 to 1030 | 897/1301 (68 %) | 27 diff (98.0 %id) | |||
TI_1948232438 | .a | 170 to 887 | 133 to 856 | 724/1062 (68 %) | 18 diff (98.4 %id) | |||
TI_1948232439 | .a | 466 to 1231 | 897 to 121 | 777/1225 (63 %) | 28 diff (97.8 %id) | |||
TI_1948232440 | .a | 297 to 1231 | 1065 to 124 | 942/1334 (70 %) | 23 diff (98.3 %id) | |||
TI_1948232739 | .a | 170 to 1063 | 136 to 1031 | 896/1313 (68 %) | 44 diff (96.7 %id) | |||
TI_1948232740 | .a | 170 to 806 | 132 to 770 | 639/1165 (54 %) | 12 diff (99.0 %id) | |||
TI_1948232742 | .a | 313 to 1231 | 1048 to 122 | 927/1282 (72 %) | 30 diff (97.7 %id) | |||
TI_1948233030 | .a | 170 to 940 | 135 to 910 | 776/1356 (57 %) | 25 diff (98.2 %id) | |||
TI_1948233031 | .a | 170 to 802 | 136 to 773 | 638/1177 (54 %) | 16 diff (98.7 %id) | |||
TI_1948233032 | .a | 466 to 1231 | 900 to 125 | 776/1420 (54 %) | 16 diff (98.9 %id) | |||
TI_154188522 | .a | 504 to 1159 | 121 to 776 | 656/949 (69 %) | 36 diff (96.3 %id) | |||
TI_154191415 | .a | 1233 to 1631 | 51 to 447 | 397/401 (99 %) | 6 diff (98.6 %id) | |||
TI_227712451 | .a | 935 to 1785 | 930 to 93 | AAA | 838/1015 (82 %) | 25 diff (97.6 %id) | ||
DB173497 | kidney, tumor tissue | .c | 1 to 480 | 2 to 482 | capped | 481/481 (100 %) | 1 diff (99.8 %id) | |
BU620839 | cell lines, Chondrosarcoma | .a | 1131 to 1780 | 668 to 19 | AAA | 650/650 (100 %) | 2 diff (99.7 %id) | |
BU633283 | cell lines, Chondrosarcoma | .a | 1109 to 1780 | 690 to 19 | AAA | 672/677 (99 %) | 7 diff (99.0 %id) | |
CD366991 | Alveolar Macrophage, lung | .a | 1087 to 1787 | 717 to 19 | AAA | 699/699 (100 %) | 6 diff (99.2 %id) | |
CN259213 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 521 to 1231 | 821 to 112 | 710/1245 (57 %) | 16 diff (98.8 %id) | ||
CN259214 | embryonic stem cells, DMSO-treated H9 cellline | .a | 361 to 1231 | 1007 to 127 | 881/1295 (68 %) | 20 diff (98.5 %id) | ||
DA431744 | colon | .a | 170 to 1060 | 134 to 1030 | capped | 897/1301 (68 %) | 27 diff (98.0 %id) | |
DA473784 | .a | 170 to 887 | 133 to 856 | capped | 724/1062 (68 %) | 18 diff (98.4 %id) | ||
BX952789 | .a | 466 to 1231 | 897 to 121 | 777/1225 (63 %) | 28 diff (97.8 %id) | |||
AA256714 | germinal center B cell | .a | 297 to 1231 | 1065 to 124 | 942/1334 (70 %) | 23 diff (98.3 %id) | ||
AI867085 | brain, tumor, 5 pooled (see description) | .a | 170 to 1063 | 136 to 1031 | AAA | 896/1313 (68 %) | 44 diff (96.7 %id) | |
BE047635 | brain, tumor, 5 pooled (see description) | .a | 170 to 806 | 132 to 770 | 639/1165 (54 %) | 12 diff (99.0 %id) | ||
BG116245 | duodenal adenocarcinoma, cell line, small intestine | .a | 313 to 1231 | 1048 to 122 | 927/1282 (72 %) | 30 diff (97.7 %id) | ||
BU196192 | large cell carcinoma, lung | .a | 170 to 940 | 135 to 910 | 776/1356 (57 %) | 25 diff (98.2 %id) | ||
BQ212668 | melanotic melanoma, skin | .a | 170 to 802 | 136 to 773 | 638/1177 (54 %) | 16 diff (98.7 %id) | ||
BQ882334 | lymph, lymphoma, cell line | .a | 466 to 1231 | 900 to 125 | 776/1420 (54 %) | 16 diff (98.9 %id) | ||
DA624167 | Kidney | .a | 504 to 1159 | 121 to 776 | capped | 656/949 (69 %) | 36 diff (96.3 %id) | |
CB137408 | Liver | .a | 1233 to 1631 | 51 to 447 | 397/401 (99 %) | 6 diff (98.6 %id) | ||
DA868653 | Prostate | .a | 935 to 1785 | 930 to 93 | capped | 838/1015 (82 %) | 25 diff (97.6 %id) | |
DA924817 | small intestine | .c | 1 to 480 | 2 to 482 | capped | 481/481 (100 %) | 1 diff (99.8 %id) | |
DB034580 | testis | .a | 1131 to 1780 | 668 to 19 | capped | 650/650 (100 %) | 2 diff (99.7 %id) | |
DB108866 | thymus | .a | 1131 to 1780 | 668 to 19 | capped | 650/650 (100 %) | 2 diff (99.7 %id) | |
BM711697 | eye, human retina | .a | 1109 to 1780 | 690 to 19 | 672/677 (99 %) | 7 diff (99.0 %id) | ||
BM705022 | eye, lens | .a | 1109 to 1780 | 690 to 19 | 672/677 (99 %) | 7 diff (99.0 %id) | ||
BU734592 | eye, lens | .a | 1087 to 1787 | 717 to 19 | AAA | 699/699 (100 %) | 6 diff (99.2 %id) | |
DB267383 | uterus | .a | 1087 to 1787 | 717 to 19 | capped | 699/699 (100 %) | 6 diff (99.2 %id) |
? | Gene Summary | Gene on genome | mRNA:.a, .b, .c, .d-u | Alternative mRNAs features, proteins, introns, exons, sequences | Expression Tissue | Function, regulation, related genes C |